-
1
المؤلفون: Lucía López Corral, Anna Sureda, Carlos Solano, Pau Abrisqueta, Juan-Manuel Sancho, Pere Barba, Guillermo Villacampa, Javier Briones, Rafael Hernani, Mi Kwon, Geltamo Spanish Groups Geth, Manuel Guerreiro, Gloria Iacoboni, José María Raya Sánchez, Alberto Mussetti, Ana Carolina Caballero, Alejandro Martin Garcia-Sancho, Juan Luis Reguera-Ortega, Rebeca Bailén, Nuria Martínez-Cibrian
المساهمون: Institut Català de la Salut, [Iacoboni G, Abrisqueta P, Barba P] Servei d’Hematologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Villacampa G] Oncology Data Science, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Martinez-Cibrian N] Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain. [Bailén R] Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Gregorio Marañón Health Research Institute (IiSGM), Madrid, Spain. [Lopez Corral L] Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain. Centro de Investigación del Cáncer-IBMCC, Salamanca, Spain. [Sanchez JM] Hematology Department, Hospital 12 de Octubre, Madrid, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Cancer Medicine
Dipòsit Digital de la UB
Universidad de Barcelona
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Iacoboni, Gloria Villacampa, Guillermo Martinez-Cibrian, Nuria Bailén, Rebeca Lopez-Corral, Lucia Sanchez, Jose M. Guerreiro, Manuel Caballero, Ana Carolina Mussetti, Alberto Sancho, Juan Manuel Hernani Morales, Rafael Abrisqueta, Pau Solano Vercet, Carlos Sureda, Anna Briones, Javier Martin Garcia-Sancho, Alejandro Kwon, Mi Reguera Ortega, Juan Luis Barba, Pere 2021 Real-World Evidence of Tisagenlecleucel for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma. Cancer Medicine 3214 3223
Scientia
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
RODERIC. Repositorio Institucional de la Universitat de Valéncia
Cancer Medicine, Vol 10, Iss 10, Pp 3214-3223 (2021)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Digital.CSIC. Repositorio Institucional del CSICمصطلحات موضوعية: Male, 0301 basic medicine, aminoácidos, péptidos y proteínas::proteínas::proteínas de membranas::receptores de superficie celular::receptores inmunológicos::receptores de antígenos::receptores de antígenos de linfocitos T [COMPUESTOS QUÍMICOS Y DROGAS], Cancer Research, non‐Hodgkin's lymphoma, Best Overall Response, hematological cancer, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Non- Hodgkin's lymphoma, Gastroenterology, 0302 clinical medicine, Medicine research, Other subheadings::/therapeutic use [Other subheadings], Càncer, B-cell lymphoma, RC254-282, Cancer, Original Research, Receptors, Chimeric Antigen, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, non‐, Standard of Care, Middle Aged, Patologia, Hodgkin&apos, Progression-Free Survival, Cytokine release syndrome, clinical cancer research, Oncology, neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células B::linfoma de células B grandes difuso [ENFERMEDADES], 030220 oncology & carcinogenesis, Cytokines, Female, Lymphoma, Large B-Cell, Diffuse, non-Hodgkin's lymphoma, medicine.medical_specialty, Receptors, Antigen, T-Cell, Cèl·lules B - Tumors - Tractament, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Investigació mèdica, Real world evidence, 03 medical and health sciences, s lymphoma, Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, B-Cell::Lymphoma, Large B-Cell, Diffuse [DISEASES], Refractory, clinical observations, Internal medicine, medicine, Humans, Radiology, Nuclear Medicine and imaging, Leukapheresis, Amino Acids, Peptides, and Proteins::Proteins::Membrane Proteins::Receptors, Cell Surface::Receptors, Immunologic::Receptors, Antigen::Receptors, Antigen, T-Cell [CHEMICALS AND DRUGS], Aged, Retrospective Studies, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, Teràpia cel·lular, Clinical Cancer Research, medicine.disease, Malaltia de Hodgkin, Non-Hodgkin's lymphoma, Lymphoma, 030104 developmental biology, Hodgkin's disease, Neoplasm Recurrence, Local, business
وصف الملف: application/pdf
-
2
المؤلفون: Xavier Muñoz-Gall, Gijs van de Wetering, Shibing Yang, Andrea García, José Luis Izquierdo-Alonso, Francisco-Javier González-Barcala, Esther Mariscal
المساهمون: Institut Català de la Salut, [González-Barcala FJ] Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain. Respiratory Medicine, Universidad de Santiago de Compostela, Santiago de Compostela, Spain. [Muñoz-Gall X] Servei de Pneumologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER of Respiratory Diseases (CIBERes), Madrid, Spain. Departament de Biologia Cel•lular, Fisiologia i Immunologia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Mariscal E, García A] GlaxoSmithKline, Madrid, Spain. [Yang S] GlaxoSmithKline, Collegeville, PA, USA. [van de Wetering G] Pharmerit International, Rotterdam, the Netherlands. [Izquierdo-Alonso JL] Medicine and Specialities Department, Universidad de Alcalá (Alcalá de Henares, Madrid), Hospital Universitario Guadalajara, Guadalajara, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: medicine.medical_specialty, Standard of care, Cost effectiveness, Cost-Benefit Analysis, Eosinophilic asthma, 03 medical and health sciences, 0302 clinical medicine, Adrenal Cortex Hormones, Internal medicine, Eosinophilia, economía y organizaciones para la atención de la salud::economía::costes y análisis de costes::análisis coste-beneficio [ATENCIÓN DE SALUD], medicine, hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::hormonas de la corteza suprarrenal [COMPUESTOS QUÍMICOS Y DROGAS], Humans, Other subheadings::/therapeutic use [Other subheadings], Eosinofília, health care economics and organizations, enfermedades hematológicas y linfáticas::enfermedades hematológicas::trastornos leucocitarios::eosinofilia [ENFERMEDADES], Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Adrenal Cortex Hormones [CHEMICALS AND DRUGS], Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, 030503 health policy & services, Health Policy, Cost-effectiveness analysis, Asthma, Anti il 5, Hormones esteroides - Ús terapèutic, Health Care Economics and Organizations::Economics::Costs and Cost Analysis::Cost-Benefit Analysis [HEALTH CARE], Spain, 030220 oncology & carcinogenesis, Cost-eficàcia, Hemic and Lymphatic Diseases::Hematologic Diseases::Leukocyte Disorders::Eosinophilia [DISEASES], Quality-Adjusted Life Years, 0305 other medical science, business, Mepolizumab, medicine.drug
وصف الملف: application/pdf
-
3
المؤلفون: Elias Jatem, Francisco Torres-Bondia, Bruno Montoro, Joan Lima, Alfons Segarra
المساهمون: Institut Català de la Salut, [Jatem E, Segarra A] Servicio de Nefrología, Hospital Arnau de Vilanova, Lleida, Spain. [Lima J] Servei de Medicina Interna, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Montoro B] Servei de Farmàcia Hospitalària, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Torres-Bondia F] Servicio de Farmacia Hospitalaria, Hospital Arnau de Vilanova, Lleida, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
Kidney International Reportsمصطلحات موضوعية: medicine.medical_specialty, Atorvastatin, 030232 urology & nephrology, enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::nefrosis::síndrome nefrótico [ENFERMEDADES], Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Nephrosis::Nephrotic Syndrome [DISEASES], 030204 cardiovascular system & hematology, Gastroenterology, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos [COMPUESTOS QUÍMICOS Y DROGAS], enfermedades nutricionales y metabólicas::enfermedades metabólicas::trastornos del metabolismo de los lípidos::dislipidemias::hiperlipidemias::hipercolesterolemia [ENFERMEDADES], 03 medical and health sciences, 0302 clinical medicine, Refractory, Clinical Research, Internal medicine, medicine, Hipercolesterolèmia - Complicacions, Inhibidors enzimàtics - Ús terapèutic - Eficàcia, Other subheadings::/therapeutic use [Other subheadings], Adverse effect, Proteinuria, hypercholesterolemia, biology, nephrotic syndrome, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, Vascular disease, PCSK9, dyslipidemia, Ronyons - Malalties, medicine.disease, PSCK9 inhibitors, Nephrology, Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors [CHEMICALS AND DRUGS], biology.protein, Creatine kinase, medicine.symptom, business, Nutritional and Metabolic Diseases::Metabolic Diseases::Lipid Metabolism Disorders::Dyslipidemias::Hyperlipidemias::Hypercholesterolemia [DISEASES], Nephrotic syndrome, medicine.drug
وصف الملف: application/pdf
-
4
المؤلفون: Gloria Fraga, Jorge González, Neus Roca, A. Madrid, Elias Jatem, Cristina Martínez, Mercedes López, Alfons Segarra
المساهمون: Institut Català de la Salut, [Roca N] Servicio Nefrologia Pediátrica, Hospital Universitari de Vic, Universitat de Vic, Barcelona, Spain. [Madrid A] Servicio de Nefrología Pediátrica, Hospital de Sant Joan de Déu de Barcelona, Barcelona, Spain. [Lopez M] Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Fraga G] Servei de Nefrologia Pediàtrica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servicio de Nefrología Pediátrica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Jatem E, Gonzalez J] Institut de Recerca Biomedica August Pi Sunyer, Lleida, Barcelona, Spain. Servicio de Nefrologia, Hospital Universitario Arnau de Vilanova, Lleida, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: CLINICAL KIDNEY JOURNAL
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
Clinical Kidney Journal
Scientia
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pauمصطلحات موضوعية: Endotype, 030232 urology & nephrology, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Gastroenterology, 0302 clinical medicine, Focal segmental glomerulosclerosis, Other subheadings::/therapeutic use [Other subheadings], 030212 general & internal medicine, Hormones, Hormone Substitutes, and Hormone Antagonists::Hormones::Adrenal Cortex Hormones [CHEMICALS AND DRUGS], Proteinuria, medicine.diagnostic_test, biology, Haptoglobin, inflammatory response, endotypes, Nephrology, idiopathic nephrotic syndrome, Renal biopsy, medicine.symptom, Glomerulosclerosi - Tractament, medicine.medical_specialty, Corticosteroides - Ús terapèutic, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Renal function, 03 medical and health sciences, Cluster analysis, Idiopathic nephrotic syndrome, Internal medicine, Biopsy, medicine, hormonas, sustitutos de hormonas y antagonistas de hormonas::hormonas::hormonas de la corteza suprarrenal [COMPUESTOS QUÍMICOS Y DROGAS], AcademicSubjects/MED00340, enfermedades urogenitales masculinas::enfermedades urológicas::enfermedades renales::nefritis::glomerulonefritis::glomeruloesclerosis focal [ENFERMEDADES], Lymphocyte populations, focal segmental glomerulosclerosis, Transplantation, Otros calificadores::/uso terapéutico [Otros calificadores], lymphocyte populations, business.industry, Interleukins, Endotypes, Inflammatory response, Original Articles, medicine.disease, interleukins, SuPAR, Male Urogenital Diseases::Urologic Diseases::Kidney Diseases::Nephritis::Glomerulonephritis::Glomerulosclerosis, Focal Segmental [DISEASES], biology.protein, business, cluster analysis
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc51a52ce4f7be6ea3eda02081348d3e
https://doi.org/10.1093/ckj/sfaa265 -
5
المؤلفون: Catherine Leger, Toshihiko Doi, Kazuhiro Nishikawa, Aliaksandr Prokharau, Suayib Yalcin, David H. Ilson, C. Faustino, Takayuki Ando, Vera Gorbunova, Wasat Mansoor, Kohei Shitara, Donia Skanji, Javier Sabater, Nadia Amellal, Michele Ghidini, Eric Van Cutsem, Maria Alsina, Edvard Zhavrid, Josep Tabernero, Mikhail Dvorkin, Hendrik-Tobias Arkenau
المساهمون: Institut Català de la Salut, [Tabernero J, Alsina M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Spain. [Shitara K, Doi T] National Cancer Center Hospital East, Chiba, Japan. [Dvorkin M] Omsk Regional Clinical Centre of Oncology, Omsk, Russia. [Mansoor W] The Christie NHS Foundation Trust, Manchester, UK, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
Gastric Cancerمصطلحات موضوعية: Male, Cancer Research, Pyrrolidines, Health-related quality of life, Medicaments antineoplàstics - Ús terapèutic, Trifluridine, tipiracil, Metastatic gastric cancer, chemistry.chemical_compound, Quality of life, Surgical oncology, Antineoplastic Combined Chemotherapy Protocols, Other subheadings::/therapeutic use [Other subheadings], ambiente y salud pública::salud pública::medidas epidemiológicas::demografía::estado de salud::calidad de vida [ATENCIÓN DE SALUD], Aged, 80 and over, Trifluridine/tipiracil, Gastroenterology, General Medicine, Middle Aged, Prognosis, humanities, Survival Rate, Oncology, Estómac - Càncer, Female, Original Article, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Stomach Neoplasms [DISEASES], Life Sciences & Biomedicine, Qualitat de vida - Avaluació, medicine.drug, Adult, MODULE, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias gástricas [ENFERMEDADES], medicine.medical_specialty, Adolescent, Adenocarcinoma, Phase 3, Placebo, Young Adult, Double-Blind Method, Stomach Neoplasms, Internal medicine, Post-hoc analysis, medicine, Humans, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Aged, Tipiracil, Science & Technology, Gastroenterology & Hepatology, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, International Agencies, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Environment and Public Health::Public Health::Epidemiologic Measurements::Demography::Health Status::Quality of Life [HEALTH CARE], chemistry, Quality of Life, Gastric cancer, business, Thymine, Follow-Up Studies, Abdominal surgery
وصف الملف: application/pdf; Print-Electronic
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f279f17b20c298de80ea1c7855af538f
https://doi.org/10.1007/s10120-020-01053-9 -
6
المؤلفون: Luojun Victor Wang, Yvonne Y. Lau, Thomas John, Giovanni Selvaggi, Filippo de Braud, Jeffrey W. Scott, Enriqueta Felip, Vanessa Giannone, O. Alejandro Balbin, Michela Maur, Daniel Shao-Weng Tan, Pilar Cazorla, Martijn P. Lolkema, Herbert H. Loong, Johan Vansteenkiste, Alice T. Shaw, Jason Baum, Geoffrey Liu
المساهمون: Medical Oncology, Institut Català de la Salut, [Felip E] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. [de Braud FG] University of Milan, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. [Maur M] AOU Policlinico of Modena, University of Modena and Reggio Emilia, Modena, Italy. [Loong HH] The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People's Republic of China. [Shaw AT] Massachusetts General Hospital, Boston, Massachusetts. [Vansteenkiste JF] University Hospital KU Leuven, Leuven, Belgium, Vall d'Hebron Barcelona Hospital Campus
المصدر: Journal of Thoracic Oncology, 15(3), 392-403. International Association for the Study of Lung Cancer
Scientiaمصطلحات موضوعية: 0301 basic medicine, Pulmonary and Respiratory Medicine, medicine.medical_specialty, Lung Neoplasms, medicine.medical_treatment, Ceritinib, NSCLC, Gastroenterology, Quimioteràpia combinada, 03 medical and health sciences, 0302 clinical medicine, SDG 3 - Good Health and Well-being, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Carcinoma, Non-Small-Cell Lung, Internal medicine, PD-1, Maculopapular rash, medicine, Humans, Anaplastic Lymphoma Kinase, Other subheadings::/therapeutic use [Other subheadings], Sulfones, Pulmons - Càncer - Quimioteràpia, Lung cancer, Adverse effect, nivolumab, Chemotherapy, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], medicine.disease, Rash, Nivolumab, Pyrimidines, 030104 developmental biology, ALK, Oncology, 030220 oncology & carcinogenesis, Cohort, medicine.symptom, business, medicine.drug
وصف الملف: application/pdf; Print-Electronic
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c585261ab269021e80247d15a18cb62
https://doi.org/10.1016/j.jtho.2019.10.006 -
7
المؤلفون: Andrés Redondo, M. Iglesias, E.M. Guerra, Ana Santaballa, L. Manso Sánchez, E. Calvo García, Ángel Fernández Cortés, Jose Alejandro Perez-Fidalgo, Y. García, Ana Oaknin, Antonio González-Martín, Mauricio Rubio, U. Bohn Sarmiento
المساهمون: Institut Català de la Salut, [Perez-Fidalgo JA] Department of Medical Oncology, Hospital Clínico Universitario de Valencia, Valencia, Spain. [Cortés A, Guerra E] Department of Medical Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain. [García Y] Department of Medical Oncology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT), Universitat Autònoma de Barcelona, Sabadell, Spain. [Iglesias M] Department of Medical Oncology, Hospital Son Llatzer, Palma De Mallorca, Spain. [Bohn Sarmiento U] Department of Medical Oncology, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas De Gran Canaria, Spain. [Oaknin A] Servei d’Oncologia Mèdica, Vall d'Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: ESMO Open
Esmo Open
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Scientiaمصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, endocrine system diseases, Anemia, medicine.medical_treatment, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], platinum-resistant recurrent ovarian cancer, neoplasias::neoplasias por localización::neoplasias de las glándulas endocrinas::neoplasias ováricas [ENFERMEDADES], Neutropenia, Other subheadings::Other subheadings::/drug therapy [Other subheadings], olaparib, Quimioteràpia combinada, Disease-Free Survival, Piperazines, Olaparib, Polyethylene Glycols, chemistry.chemical_compound, pegylated liposomal doxorubicin, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Clinical endpoint, Humans, Other subheadings::/therapeutic use [Other subheadings], Adverse effect, Original Research, Ovarian Neoplasms, Chemotherapy, BRCA wild-type, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, Neoplasms::Neoplasms by Site::Endocrine Gland Neoplasms::Ovarian Neoplasms [DISEASES], terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Ovaris - Càncer - Tractament, medicine.disease, PARP inhibitor, chemistry, Doxorubicin, Avaluació de resultats (Assistència sanitària), Phthalazines, Female, Neoplasm Recurrence, Local, Ovarian cancer, business
وصف الملف: application/pdf
-
8
المؤلفون: Moreno-García, Estela, Puerta-Alcalde, Pedro, Gariup, Giuseppe, Fernández-Ruiz, Mario, López Cortés, Luis Eduardo, Cuervo, Guillermo, Salavert, Miguel, Merino, Paloma, Machado, Marina, Guinea, Jose, García-Rodríguez, Julio, Garnacho-Montero, Jose, Cardozo, Celia, Peman, Javier, Montejo, Miguel, Fortún, Jesús, Almirante Gragera, Benito, Castro, Carmen, Rodríguez-Baño, Jesús, Aguado, José María, Martínez, Jose Alfredo, Carratalà, Jordi, Soriano, Alex, Garcia-Vidal, Carolina, Universitat Autònoma de Barcelona
المساهمون: European Institute of Innovation and Technology, European Commission, Ministerio de Sanidad y Consumo (España), Instituto de Salud Carlos III, Institut Català de la Salut, [Moreno-García E, Puerta-Alcalde P, Gariup G] Hospital Clínic, Universitat de Barcelona, Barcelona, Spain. [Fernández-Ruiz M] Hospital Universitario '12 de Octubre', Instituto de Investigación Hospital '12 de Octubre' (imas+12), Universidad Complutense, Madrid, Spain. [López Cortés LE] Unidad de Gestión Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, CSIC, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain. [Cuervo G] Hospital Universitari de Bellvitge, IDIBELL (Institut d’Investigació Biomèdica de Bellvitge), Universitat de Barcelona, Barcelona, Spain. [Almirante B] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
Digital.CSIC. Repositorio Institucional del CSIC
instname
Open Forum Infectious Diseases
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Dipòsit Digital de la UB
Universidad de Barcelona
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelonaمصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Echinocandin, antifungal, candidemia, de-escalation, invasive candidiasis, outcome, 030106 microbiology, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Therapeutics, Medicaments antifúngics - Ús terapèutic, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Candida parapsilosis, Antifungal, Major Articles, law.invention, 03 medical and health sciences, 0302 clinical medicine, law, Internal medicine, Post-hoc analysis, medicine, Other subheadings::/therapeutic use [Other subheadings], 030212 general & internal medicine, Micosi - Tractament, Outcome, acciones y usos químicos::acciones farmacológicas::usos terapéuticos::antiinfecciosos::antifúngicos [COMPUESTOS QUÍMICOS Y DROGAS], biology, Càndida, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, Bacterial Infections and Mycoses::Infection::Sepsis::Fungemia::Candidemia [DISEASES], Candidiasis, Candidemia, Odds ratio, Terapèutica, biology.organism_classification, Intensive care unit, Confidence interval, De-escalation, Invasive candidiasis, AcademicSubjects/MED00290, Infectious Diseases, Oncology, Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Anti-Infective Agents::Antifungal Agents [CHEMICALS AND DRUGS], Candidiasi, infecciones bacterianas y micosis::infección::sepsis::fungemia::candidemia [ENFERMEDADES], business, Fluconazole, medicine.drug, Cohort study
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::987173b69a59554168aec0ac98f900c0
https://pubmed.ncbi.nlm.nih.gov/35615301 -
9
المؤلفون: Gerald W. Prager, Josep Tabernero, Nadia Amellal, Eric Van Cutsem, Julien Taieb, Catherine Leger, Fortunato Ciardiello, Marwan Fakih, Ronan Fougeray
المساهمون: Tabernero, J., Taieb, J., Prager, G. W., Ciardiello, F., Fakih, M., Leger, C., Fougeray, R., Amellal, N., Van Cutsem, E., Institut Català de la Salut, [Tabernero J] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Institute of Oncology (VHIO), Barcelona, Spain. [Taieb J] Service d'hépatogastroentérologie et d'oncologie digestive, Université de Paris, Paris Descartes University, Georges Pompidou European Hospital, 20 rue Leblanc, Paris, France. [Prager GW] Department of Medicine I, Comprehensive Cancer Centre Vienna, Medical University Vienna, Josefstaedter Str. 23/15, Vienna, Austria. [Ciardiello F] Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Via S. Pansini, Naples, Italy. [Fakih M] Briskin Center for Clinical Research, Section Head and GI Medical Oncology, City of Hope Comprehensive Cancer Center, 1500 E Duarte St, Duarte, CA, USA. [Leger C] Institut de Recherches Internationales Servier, 50 rue Carnot, Suresnes Cedex, France, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: Oncology, Male, Cancer Research, Pyrrolidines, genetic structures, Colorectal cancer, Medicaments antineoplàstics - Ús terapèutic, Trifluridine, law.invention, trifluridine/tipiracil, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Còlon - Càncer, Antineoplastic Combined Chemotherapy Protocols, Multicenter Studies as Topic, Other subheadings::/therapeutic use [Other subheadings], 030212 general & internal medicine, Neoplasm Metastasis, third line, Randomized Controlled Trials as Topic, third-line, Aged, 80 and over, metastatic colorectal cancer, General Medicine, Middle Aged, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias gastrointestinales::neoplasias intestinales::neoplasias colorrectales [ENFERMEDADES], Bevacizumab, Drug Combinations, 030220 oncology & carcinogenesis, Recte - Càncer, Female, Colorectal Neoplasms, Life Sciences & Biomedicine, medicine.drug, Adult, medicine.medical_specialty, bevacizumab, 03 medical and health sciences, Young Adult, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Gastrointestinal Neoplasms::Intestinal Neoplasms::Colorectal Neoplasms [DISEASES], Phase III, Refractory, Internal medicine, mental disorders, parasitic diseases, medicine, Humans, Thymidine phosphorylase, terapéutica::protocolos clínicos::protocolos antineoplásicos::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Tipiracil, Aged, Science & Technology, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, nutritional and metabolic diseases, Therapeutics::Clinical Protocols::Antineoplastic Protocols::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, eye diseases, nervous system diseases, refractory, chemistry, Third line, Clinical Trials, Phase III as Topic, randomized controlled trial, FTD/TPI, business, Thymine
وصف الملف: Print-Electronic; application/pdf
-
10
المؤلفون: Robin Wiltshire, Holger Thurm, Alessandra Bearz, Ben Solomon, Benjamin Besse, Antonello Abbattista, Enriqueta Felip, Todd M. Bauer, D.R. Camidge, Alice T. Shaw, F. Toffalorio, Solange Peters, Jessica Bauman, Gerson Peltz
المساهمون: Institut Català de la Salut, [Felip E] Vall d'Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. UVic-UCC, IOB-Quiron, Barcelona, Spain. [Shaw AT] Massachusetts General Hospital, Boston, USA. [Bearz A] National Institute for Cancer Research, Aviano, Italy. [Camidge DR] University of Colorado, Aurora, USA. [Solomon BJ] Peter MacCallum Cancer Centre, Melbourne, Australia. [Bauman JR] Fox Chase Cancer Center, Philadelphia, USA, Vall d'Hebron Barcelona Hospital Campus
المصدر: Scientia
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Lung Neoplasms, Lactams, medicine.drug_class, medicine.medical_treatment, Lactams, Macrocyclic, Phases of clinical research, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Aminopyridines, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Enzyme Inhibitors::Protein Kinase Inhibitors [CHEMICALS AND DRUGS], Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, hemic and lymphatic diseases, Carcinoma, Non-Small-Cell Lung, medicine, Anaplastic lymphoma kinase, Humans, In patient, Other subheadings::/therapeutic use [Other subheadings], Lung cancer, Protein Kinase Inhibitors, Chemotherapy, business.industry, acciones y usos químicos::acciones farmacológicas::mecanismos moleculares de acción farmacológica::inhibidores enzimáticos::inhibidores de proteínas cinasas [COMPUESTOS QUÍMICOS Y DROGAS], Otros calificadores::/uso terapéutico [Otros calificadores], Receptor Protein-Tyrosine Kinases, Hematology, Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], medicine.disease, Lorlatinib, respiratory tract diseases, Proteïnes quinases - Inhibidors, 030104 developmental biology, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, Pyrazoles, business, Pulmons - Càncer - Tractament
وصف الملف: application/pdf
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0eb4646d7c4532593199c01506e214e5
https://pubmed.ncbi.nlm.nih.gov/33741444
إعادة تعيين المنقحات
عرض المنقحات (%%عد%%)
PDF full text from Publisher 
Full Text via ClinicalKey